Peroxisomal beta-oxidation enzyme proteins in the Zellweger syndrome. 1985

J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram

The absence of peroxisomes in patients with the cerebro-hepato-renal (Zellweger) syndrome is accompanied by a number of biochemical abnormalities, including an accumulation of very long-chain fatty acids. We show by immunoblotting that there is a marked deficiency in livers from patients with the Zellweger syndrome of the peroxisomal beta-oxidation enzyme proteins acyl-CoA oxidase, the bifunctional protein with enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activities and 3-oxoacyl-CoA thiolase. Using anti-(acyl-CoA oxidase), increased amounts of cross-reactive material of low Mr were seen in the patients. With anti-(oxoacyl-CoA thiolase), high Mr cross-reactive material, presumably representing precursor forms of 3-oxoacyl-CoA thiolase, was detected in the patients. Catalase protein was not deficient, in accordance with the finding that catalase activity is not diminished in the patients. Thus in contrast to the situation with catalase functional peroxisomes are required for the stability and normal activity of peroxisomal beta-oxidation enzymes.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D007690 Polycystic Kidney Diseases Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance. Kidney, Polycystic,Polycystic Kidney,Polycystic Kidney Disease,Polycystic Kidneys,Polycystic Renal Disease,Disease, Polycystic Kidney,Disease, Polycystic Renal,Diseases, Polycystic Kidney,Diseases, Polycystic Renal,Kidney Disease, Polycystic,Kidney Diseases, Polycystic,Kidneys, Polycystic,Polycystic Renal Diseases,Renal Disease, Polycystic,Renal Diseases, Polycystic
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008830 Microbodies Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes. Glycosomes,Glycosome,Microbody
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D004746 Enoyl-CoA Hydratase An enzyme that catalyzes reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA. EC 4.2.1.17. 3-Hydroxyacyl CoA Hydrolyases,3-Hydroxyacyl Dehydratases,Crotonase,Enoyl Hydrase,beta-Hydroxyacyl Dehydratases,Enoyl CoA Hydratases,beta-Hydroxyacyl-CoA Dehydrases,trans-2-Enoyl-Coenzyme A Hydratase,3 Hydroxyacyl CoA Hydrolyases,3 Hydroxyacyl Dehydratases,CoA Hydratases, Enoyl,CoA Hydrolyases, 3-Hydroxyacyl,Dehydrases, beta-Hydroxyacyl-CoA,Dehydratases, 3-Hydroxyacyl,Dehydratases, beta-Hydroxyacyl,Enoyl CoA Hydratase,Hydrase, Enoyl,Hydratase, Enoyl-CoA,Hydratase, trans-2-Enoyl-Coenzyme A,Hydratases, Enoyl CoA,Hydrolyases, 3-Hydroxyacyl CoA,beta Hydroxyacyl CoA Dehydrases,beta Hydroxyacyl Dehydratases,trans 2 Enoyl Coenzyme A Hydratase
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D006529 Hepatomegaly Enlargement of the liver. Enlarged Liver,Liver, Enlarged
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
April 1986, Clinica chimica acta; international journal of clinical chemistry,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
January 1986, Journal of inherited metabolic disease,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
February 1988, Clinica chimica acta; international journal of clinical chemistry,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
January 1988, Journal of inherited metabolic disease,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
January 1990, Journal of inherited metabolic disease,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
January 1997, Ryoikibetsu shokogun shirizu,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
July 1988, Clinica chimica acta; international journal of clinical chemistry,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
August 2000, Ugeskrift for laeger,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
January 1993, Journal of inherited metabolic disease,
J M Tager, and W A Van der Beek, and R J Wanders, and T Hashimoto, and H S Heymans, and H Van den Bosch, and R B Schutgens, and A W Schram
January 2001, Molecular genetics and metabolism,
Copied contents to your clipboard!